WithdrawnNot Applicable

Bladder Lavage as Decontamination Method for Asymptomatic Bacteriuria With Uropathogens in Catheterized Patients

Stopped: no clinical investigator present

Belgium0Started 2013-01

Plain-language summary

In patients with advanced multiple sclerosis, permanent urinary catheters are often used to manage the urinary incontinence and bladder emptying problems. These catheters will lead to urinary tract infection, blocking of the catheter etc.. Especially infections with certain bacteria such as proteus, enterobacteriaceae and ESBL producing enterobacteriaceae and pseudomonas can pose a problem for the hospital infection control and for the patient. This study wants to evaluate the potential role of regular bladder lavage with saline, a solution of betadine, an acid solution of acetic acid and of URotainer Twin Suby G ( Braun)in the decontamination of these bladders and the prevention of clinically relevant urinary tract infections.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with an indwelling catheter * catheter associated bacteriuria with proteus, enterobacteriaceae or pseudomonas * willing and able to give informed consent to the study Exclusion Criteria: * patients with a clinically relevant UTI ( fever, pain or cloudy urine) * cognitively impaired patients * patients not able or willing to give informed consent * patients with allergies for ISobetadine dermicum or other substances used in the protocol * patients who only have a catheter for less than 1 month * patients taking systemic antibiotics during the last 48h

What they're measuring

urinary culture

Timeframe: day 2 and day 5 after last bladder lavage

Trial details

NCT IDNCT01772875

SponsorNational Multiple Sclerosis Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-12